These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological investigations following an adverse reaction to oxybuprocaine eye drops. Sewell WA; Croucher JJ; Bird AG Br J Ophthalmol; 1999 May; 83(5):632. PubMed ID: 10917687 [No Abstract] [Full Text] [Related]
3. [Particularly rapid appearance of a severe toxic keratopathy caused by oxybuprocaine]. Jallet G; Cleirens S; Girard E; Béchetoille A Bull Soc Ophtalmol Fr; 1980; 80(4-5):385-7. PubMed ID: 7460172 [No Abstract] [Full Text] [Related]
4. Ultrastructural alterations in the endothelium in a patient with topical anesthetic abuse keratopathy. Risco JM; Millar LC Ophthalmology; 1992 Apr; 99(4):628-33. PubMed ID: 1584582 [TBL] [Abstract][Full Text] [Related]
5. Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome. Ansari H; Weinberg L; Spencer N BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24038291 [TBL] [Abstract][Full Text] [Related]
7. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs. Douet JY; Michel J; Regnier A Am J Vet Res; 2013 Oct; 74(10):1321-6. PubMed ID: 24066916 [TBL] [Abstract][Full Text] [Related]
8. Toxic keratopathy associated with abuse of low-dose anesthetic: a case report. Chen HT; Chen KH; Hsu WM Cornea; 2004 Jul; 23(5):527-9. PubMed ID: 15220742 [TBL] [Abstract][Full Text] [Related]
9. Fibrinous iritis due to oxybuprocaine. Haddad R Br J Ophthalmol; 1989 Jan; 73(1):76-7. PubMed ID: 2920158 [TBL] [Abstract][Full Text] [Related]
12. [Oxybuprocaine drops and eyedrops should not be given to patientson prescription]. Cruysberg JR Ned Tijdschr Geneeskd; 1990 Sep; 134(39):1910. PubMed ID: 2215773 [No Abstract] [Full Text] [Related]
13. Corneal thickness values before and after oxybuprocaine 0.4% eye drops. Asensio I; Rahhal SM; Alonso L; Palanca-Sanfrancisco JM; Sanchis-Gimeno JA Cornea; 2003 Aug; 22(6):527-32. PubMed ID: 12883345 [TBL] [Abstract][Full Text] [Related]
14. Topical anesthetic abuse ring keratitis: report of four cases. Varga JH; Rubinfeld RS; Wolf TC; Stutzman RD; Peele KA; Clifford WS; Madigan W Cornea; 1997 Jul; 16(4):424-9. PubMed ID: 9220240 [TBL] [Abstract][Full Text] [Related]
15. Corneal thickness differences between sexes after oxybuprocaine eye drops. Fernandez-Garcia P; Cerviño A; Quiles-Guiñau L; Albarran-Diego C; Garcia-Lazaro S; Sanchis-Gimeno JA Optom Vis Sci; 2015 Jan; 92(1):89-94. PubMed ID: 25360701 [TBL] [Abstract][Full Text] [Related]
16. Corneal anesthesia following application of 0.4% oxybuprocaine hydrochloride ophthalmic solution to normal feline eyes. Giudici V; Baeza S; Douet JY; Regnier A Vet Ophthalmol; 2015 Mar; 18(2):141-6. PubMed ID: 24824864 [TBL] [Abstract][Full Text] [Related]
18. Recurrent corneal ulceration as late complication of toxic keratitis. Wasserman BN; Liss RP; Santander SH Br J Ophthalmol; 2002 Feb; 86(2):245-6. PubMed ID: 11815357 [No Abstract] [Full Text] [Related]
19. Degree of corneal anesthesia after topical application of 0.4% oxybuprocaine ophthalmic solution in normal equids. Little E; Yvorchuk-St Jean K; Little W; Sithole F; St Jean G Can J Vet Res; 2016 Oct; 80(4):329-334. PubMed ID: 27733789 [TBL] [Abstract][Full Text] [Related]